Lv62
1690 积分 2024-05-21 加入
The mechanism of action of oxytocin antagonist nolasiban in ART in healthy female volunteers
1个月前
已关闭
Epidemiology, pathogenesis, biology and evolving management of MSI-H/dMMR cancers
1个月前
已完结
Pilot Prospective Evaluation of 18F-Alfatide II for Detection of Skeletal Metastases
1个月前
已完结
宫腔粘连临床诊疗中国专家共识
1个月前
已完结
Head-to-head evaluation of [18F]FDG PET/CT and [68Ga]Ga-HX01 PET/MR in sarcoma patients
1个月前
已完结
Phase I study of [68Ga]Ga-HX01 for targeting integrin αvβ3 and CD13 in healthy and malignancy subjects
1个月前
已完结
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
2个月前
已完结
Glecirasib in KRASG12C-mutated nonsmall-cell lung cancer: a phase 2b trial
2个月前
已完结
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial
2个月前
已完结
Garsorasib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 2 trial
2个月前
已完结
皖公网安备34019202002308
